BR112015016358A2 - composições nutritivas contendo um componente neurológico e usos das mesmas - Google Patents

composições nutritivas contendo um componente neurológico e usos das mesmas

Info

Publication number
BR112015016358A2
BR112015016358A2 BR112015016358A BR112015016358A BR112015016358A2 BR 112015016358 A2 BR112015016358 A2 BR 112015016358A2 BR 112015016358 A BR112015016358 A BR 112015016358A BR 112015016358 A BR112015016358 A BR 112015016358A BR 112015016358 A2 BR112015016358 A2 BR 112015016358A2
Authority
BR
Brazil
Prior art keywords
nutritional compositions
neurological component
neurological
compositions containing
component
Prior art date
Application number
BR112015016358A
Other languages
English (en)
Inventor
Kuang Chenzhong
Hondmann Dirk
K Poels Eduard
Xiao Yan
Jouni Zeina
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of BR112015016358A2 publication Critical patent/BR112015016358A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid

Abstract

resumo patente de invenção: "composições nutritivas contendo um componente neurológico e usos das mesmas". a presente invenção se refere a composições nutritivas compreendendo um componente neurológico, em que, o componente neurológico pode promover o desenvolvimento do cérebro e do sistema nervoso e adicionalmente fornecer a proteção e o reparo neurológicos. o componente neurológico pode incluir a fosfatidiletanolamina, a esfingomielina, o difosfato de citidina-colina, a ceramida, a uridina, pelo menos um gangliosídio, e misturas dos mesmos. a divulgação adicionalmente se refere a métodos para promover a saúde cerebral e do sistema nervoso fornecendo as ditas composições nutritivas a pacientes alvos, o que inclui pacientes pediátricos.
BR112015016358A 2013-01-11 2013-12-12 composições nutritivas contendo um componente neurológico e usos das mesmas BR112015016358A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/739,787 US20140199265A1 (en) 2013-01-11 2013-01-11 Nutritional compositions containing a neurologic component and uses thereof
PCT/US2013/074521 WO2014109862A1 (en) 2013-01-11 2013-12-12 Nutritional compositions containing a neurologic component and uses thereof

Publications (1)

Publication Number Publication Date
BR112015016358A2 true BR112015016358A2 (pt) 2017-07-11

Family

ID=49887324

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015016358A BR112015016358A2 (pt) 2013-01-11 2013-12-12 composições nutritivas contendo um componente neurológico e usos das mesmas

Country Status (16)

Country Link
US (1) US20140199265A1 (pt)
EP (1) EP2943079A1 (pt)
CN (1) CN104883909A (pt)
AR (1) AR094413A1 (pt)
AU (1) AU2013372898B2 (pt)
BR (1) BR112015016358A2 (pt)
CA (1) CA2912246A1 (pt)
HK (1) HK1214090A1 (pt)
IN (1) IN2015DN04207A (pt)
MX (1) MX2015008585A (pt)
PE (1) PE20151771A1 (pt)
PH (1) PH12015501504A1 (pt)
RU (1) RU2015120263A (pt)
SG (1) SG11201503682VA (pt)
TW (1) TW201440669A (pt)
WO (1) WO2014109862A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9241923B2 (en) 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US9226914B2 (en) 2013-07-16 2016-01-05 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
US10028519B2 (en) * 2014-03-05 2018-07-24 Mead Johnson Nutrition Company Nutritional compositions containing ceramide and uses thereof
US20150305359A1 (en) * 2014-04-24 2015-10-29 Mead Johnson Nutrition Company Nutritional compositions directed to subjects having cow's milk protein allergies
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
CN106998774A (zh) * 2014-11-26 2017-08-01 雅培制药有限公司 包含人乳低聚糖、多不饱和脂肪酸、核苷酸以及叶黄素的婴儿配方
US10617701B2 (en) * 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US20170006897A1 (en) * 2015-07-10 2017-01-12 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
EP3389409A1 (en) * 2015-12-14 2018-10-24 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
AU2016374155A1 (en) * 2015-12-14 2018-04-19 Société des Produits Nestlé S.A. Nutritional composition and infant formula for promoting myelination of the brain
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
CN105638906A (zh) * 2016-01-11 2016-06-08 东北农业大学 一种满足婴儿的脂质个性化营养需求的婴儿配方奶粉
WO2017176109A1 (en) 2016-04-04 2017-10-12 N.V. Nutricia Method for reducing or preventing global developmental delay in children
CN110325054A (zh) * 2017-05-04 2019-10-11 小利兰·斯坦福大学托管委员会 促进神经发育的食物组合物和与其相关的试剂盒、系统和方法
US20200208103A1 (en) * 2017-07-20 2020-07-02 Riken Method for maturation of retinal tissue containing continuous epithelium
WO2019074617A2 (en) * 2017-09-14 2019-04-18 Kilman Clarke Lewis NEUPANEX ®: NEUROGENESIS, NEUROREGENERATIONAL AND NEUROPROTECTIVE SUPPLEMENT SUPPLEMENT COMBINATION
US11357803B2 (en) * 2017-09-22 2022-06-14 Iowa State University Research Foundation, Inc. Probiotic compositions for production of dopamine
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
MX2020006768A (es) 2017-12-29 2020-08-24 Kraft Foods Group Brands Llc Estabilidad oxidativa mejorada de emulsiones de aceite-en-agua utilizando estabilizadores naturales.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
US20050013884A1 (en) * 2003-07-16 2005-01-20 Rennels M. Scott Compositions and methods for treating heart disease
ES2314461T3 (es) * 2003-10-24 2009-03-16 N.V. Nutricia Composicion simbiotica para bebes.
TW200628075A (en) * 2004-10-12 2006-08-16 Katrina Fletcher Dairy product and process
AU2012203650B2 (en) * 2005-05-23 2014-09-18 Massachusetts Institute Of Technology Compositions containing PUFA and methods of use thereof
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
US20130172286A1 (en) * 2010-03-31 2013-07-04 Vegenat, S.A. Functional Food Supplement Intended, In Particular, For Nutrition And For Prevention And Improvement of Neurological Alterations, Neurodegenerative Alterations Or Cognitive Disorders
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma

Also Published As

Publication number Publication date
EP2943079A1 (en) 2015-11-18
CN104883909A (zh) 2015-09-02
HK1214090A1 (zh) 2016-07-22
AR094413A1 (es) 2015-07-29
AU2013372898B2 (en) 2016-12-08
PH12015501504A1 (en) 2015-09-28
CA2912246A1 (en) 2014-07-17
WO2014109862A1 (en) 2014-07-17
AU2013372898A1 (en) 2015-05-28
IN2015DN04207A (pt) 2015-10-16
MX2015008585A (es) 2015-09-04
RU2015120263A (ru) 2017-02-16
SG11201503682VA (en) 2015-06-29
PE20151771A1 (es) 2015-12-02
US20140199265A1 (en) 2014-07-17
TW201440669A (zh) 2014-11-01

Similar Documents

Publication Publication Date Title
BR112015016358A2 (pt) composições nutritivas contendo um componente neurológico e usos das mesmas
BR112014016648A2 (pt) derivados policíclicos, processo de preparação e uso farmacêutico dos mesmos
BR112015004530A8 (pt) montagem de equipamento de impressão tridimensional e método para preparação de artigos impressos tridimensionalmente
BR112014007654A8 (pt) Inibidores de lrrk2 quinase macrocíclicos.
BR112014025711A8 (pt) composto, medicamento, e, uso de um composto
BR112014022000A2 (pt) compostos à base de pirazol[1,5-a]pirimidina, seu uso e composições que os compreende
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
BR112015002118A2 (pt) 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
DOP2014000059A (es) Derivados de estra–1,3,5(10),16–tetraen–3–carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
BR112015027440A2 (pt) DERIVADO DE [1,2,4]TRIAZOL[4,3-a]PIRIDINA, MÉTODO DE PREPA-RAÇÃO OU APLICAÇÃO MÉDICA DO DERIVADO
BR112015017775A2 (pt) enzima cistationina beta-sintase para o tratamento de homocistinúria
BR112014019399A2 (pt) métodos de tratamento da fibrose
ECSP15000868A (es) Derivados de estra–1,3,5(10),16–tetraeno 3–sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos
BR112015021332A2 (pt) sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
GT201400242A (es) "nuevos compuestos de pirazol"
BR112018000242A2 (pt) composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico
BR112014021133A2 (pt) composto; composição farmacêutica; método para tratar, administrar e/ou reduzir as doenças ou distúrbios, síndrome ou afecções associados à modulação de receptor de captação de cálcio; e processo para a preparação de composto
BR112017005299A2 (pt) inibidores de lrrk2 cinase macrocíclicos
BR112015030431A2 (pt) formulação de liberação modificada
BR112015005942A2 (pt) extratos de cynara scolymus, coffea spp. e olea europaea para tratamento de síndrome metabólica
BR112015022513A2 (pt) produto e método para tratamento de diarreia
BR112017021583A2 (pt) métodos para o tratamento de transtornos inflamatórios
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
BR112015030099A2 (pt) marcador para desordens de esfingomielinase ácida e usos do mesmo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23L 1/30 , A23L 1/29 , A61K 31/164 , A61K 31/685 , A61K 31/688 , A61K 31/7032 , A61K 31/7068 , A61K 31/7072

Ipc: A61K 31/164 (2000.01), A61K 31/685 (1974.07), A61K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL